Skip to main content

ADVERTISEMENT

John Edwards, MD, MBA

10/08/2020
Abstract: Background: Lumateperone is an FDA-approved antipsychotic to treat schizophrenia and depressive episodes associated with bipolar I or bipolar II disorder. In a Phase 3 clinical ...
01/19/2023